苯二氮䓬类药物增加创伤患者感染与血栓并发症风险
本研究基于2003至2018年宾夕法尼亚创伤结局研究数据库,分析入院尿药筛苯二氮䓬类阳性创伤患者感染(肺炎、尿路感染、脓毒症、伤口及软组织感染)与血栓(肺栓塞或深静脉血栓)并发症的关系。33,260例(20.4%)患者尿药筛阳性;单因素分析显示苯二氮䓬类阳性者感染(3.33% vs 1.76%,p<0.001)和血栓(2.84% vs 1.62%,p<0.001)并发症发生率更高。多因素分析显示苯二氮䓬类显著增加感染和血栓并发症的比值比;苯二氮䓬类阳性且发生感染者后续发生血栓并发症的调整OR为1.65(p<0.001)。作者认为创伤患者入院尿药筛苯二氮䓬类阳性与感染和血栓并发症风险升高相关。
要点
- 创伤患者入院尿药筛苯二氮䓬类阳性率20.4%(33,260例),阳性者感染并发症发生率3.33% vs 阴性者1.76%(p<0.001)。
- 苯二氮䓬类阳性者血栓并发症发生率2.84% vs 阴性者1.62%(p<0.001)。
- 多因素分析显示苯二氮䓬类显著增加感染和血栓并发症的比值比。
- 苯二氮䓬类阳性且发生感染的患者,后续血栓并发症调整OR 1.65(p<0.001)。
- 证据等级为流行病学III级,属数据库回顾性分析。
适用人群与场景
- 2003至2018年提交至宾夕法尼亚创伤结局研究数据库的全部创伤患者。
- 分析对象为入院尿药筛苯二氮䓬类阳性的创伤患者。
诊断标准与关键阈值
- 感染并发症定义:肺炎、尿路感染、脓毒症、伤口感染及软组织感染。
- 血栓并发症定义:存在肺栓塞或深静脉血栓。
- 暴露定义:入院尿药筛苯二氮䓬类阳性。
研究设计与关键结果
- 研究类型:基于宾夕法尼亚创伤结局研究数据库2003至2018年数据的流行病学分析。
- 共3,393例(2.08%)发生感染并发症,3,048例(1.87%)发生血栓并发症。
- 33,260例(20.4%)入院尿药筛苯二氮䓬类阳性。
- 单因素分析:苯二氮䓬类阳性者感染并发症发生率3.33% vs 阴性者1.76%(p<0.001);血栓并发症发生率2.84% vs 阴性者1.62%(p<0.001)。
- 多因素分析:苯二氮䓬类显著增加感染和血栓并发症的比值比。
- 苯二氮䓬类阳性且发生感染的患者,后续发生血栓并发症的调整OR为1.65(p<0.001)。
证据类型、等级与局限
- 证据类型:流行病学数据库分析,证据等级III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,创伤患者入院尿药筛苯二氮䓬类阳性与感染和血栓并发症风险升高相关;苯二氮䓬类阳性且发生感染者血栓并发症风险进一步升高。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Benzodiazepines (BZDs) modulate peripheral γ-amino-butyric acid type A on macrophages causing immunomodulation. They inhibit proinflammatory cytokines increasing infections. Prior studies have also shown that infections can increase thrombotic complications. We sought to examine this relationship in trauma patients. We hypothesized that the presence of BZDs on admission urine drug screen (UDS) would increase rates of both complications.
METHODS: All patients submitted to the Pennsylvania Trauma Outcome Study database from 2003 to 2018 were queried. Those with a positive UDS for BZDs were analyzed. Infectious complications were defined as pneumonia, urinary tract infection, sepsis, wound, and soft tissue infection, and thrombotic complications were defined as presence of pulmonary embolism or deep vein thrombosis. Logistic regressions controlling for demographic and injury covariates assessed the adjusted impact of BZDs on infectious and thrombotic complications.
RESULTS: A total of 3,393 patients (2.08%) had infectious complications, and 3,048 (1.87%) had thrombotic complications. Furthermore, 33,260 patients (20.4%) had a positive UDS for BZDs on admission. Univariate analysis showed that those positive for BZDs had higher rates of infectious (3.33% vs. 1.76%, p < 0.001) and thrombotic (2.84% vs. 1.62%, p < 0.001) complications. Multivariate analysis revealed that BZDs significantly increased the odds of infectious and thrombotic complications. Patients who tested positive for BZDs and subsequently developed infection had increased odds (adjusted odds ratio, 1.65; p < 0.001) of developing thrombotic complications.
CONCLUSION: Trauma patients with a positive UDS for BZDs had higher odds of both infectious and thrombotic complications. Moreover, odds of thrombotic complications were higher in those with infections.
LEVEL OF EVIDENCE: Epidemiological, level III.
参考来源
- Skicki E, Morgan M, Brown C, et al. Benzodiazepines increase the likelihood of both infectious and thrombotic complications. J Trauma Acute Care Surg. 2021. PMID: 34144564. doi:10.1097/TA.0000000000003134
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。